Senior insider sale
Chief Financial Officer at ADAPTIMMUNE THERAPEUTICS PLC — senior position signals high conviction
$52.4K
90.17K shares
What this filing means
RAWCLIFFE ADRIAN plans to sell 90.17K shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $52.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/17/2025ACC: 0001970051-25-000006
Officer· Chief Financial Officer
Since Jan 2019
90.17K
Shares to sell
$52.4K
Approx. market value
30.60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Sell to cover exercise (cashless)
COMPENSATION
1/17/2025
30.60KTotal acquired30.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2025 | Sell to cover exercise (cashless) COMPENSATION | 30.60K | — |
| Total | 30.60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
29.10K
Market value
$16.7K
1/15/2025
—Completed
Units to sell
30.47K
Market value
$17.9K
1/13/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
30.60K
Market value
$17.8K
1/17/2025
Total
Units
90.17K
Value
$52.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/15/2025 | 29.10K | $16.7K | — | Completed |
1/13/2025 | 30.47K | $17.9K | — | Completed |
| Planned — Approximate Date | ||||
1/17/2025 | 30.60K | $17.8K | NASDAQ | Planned |
| Total | 90.17K | $52.4K | ||